Spark Therapeutics (ONCE) Priced

Developing gene therapy treatments for orphan retinal dystrophies.

Health Care - Biotechnology

IPO Performance
Latest Trade $64.49 0.00 (0.0%)
First Day Return 117.4%
Return from IPO 180.4%
 
Spark Therapeutics IPO News more
  • .
IPO Data
IPO File Date 12/30/2014
Offer Price $23.00
Price Range $19.00 - $21.00
Offer Shares (mm) 7.0
Deal Size ($mm) 161
 
IPO Data
IPO Date 01/29/2015
Offer Price $23.00
Price Range $19.00 - $21.00
Offer Shares (mm) 7.0
Deal Size ($mm) $161
 
Underwriters
more
Business Overview
Developing gene therapy treatments for orphan retinal dystrophies.
Developing gene therapy treatments for orphan retinal dystrophies.
more
Company Data
Headquarters Philadelphia, PA
Founded 2013
Employees 47
Website www.sparktx.com
 

Performance vs. IPO Index (IPOUSA)